Our study establishes a previously unrecognized PAI-1-c-Myc-WWP1/TRIM65 axis governing tubular maladaptive repair and positions WWP1 as a potentially new therapeutic target for slowing CKD progression. Here, MYC is linked to chronic kidney disease.